Edison Reports Promising Interim Data from Ongoing Orotecan® Clinical Trial
08 Apr 2024 //
PR NEWSWIRE
Edison Oncology Announces Presentation of Two Scientific Posters at AACR Meeting
20 Apr 2023 //
PR NEWSWIRE
Edison Oncology Partners DNA-damage Response Inhibitor Program with Rakovina
31 Mar 2021 //
PRNEWSWIRE